期刊
ONCOLOGY REPORTS
卷 46, 期 2, 页码 -出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2021.8108
关键词
rhomboid domain containing 2; WW domain-containing oxidoreductase; TGF beta signaling; breast cancer
类别
资金
- National Agency of Scientific and Technological Promotion [PICT-2017-0418, PICT-2018-01403]
- CONICET [PIP0159]
- Leukemia and Lymphoma Society Specialized Center of Research [7016-18]
Rhomboid pseudoproteases such as RHBDD2 play a role in regulating the activity of target proteins in mammary gland development and breast cancer. Interaction studies showed a physical association between RHBDD2 and WWOX in normal and cancer cells, suggesting a potential involvement in breast epithelial cell proliferation and differentiation. WWOX, as a novel target of RHBDD2, may modulate gene expression in breast cells through the TGF beta/SMAD3 signaling pathway.
Rhomboid pseudoproteases are catalytically inactive members of the rhomboid superfamily that modulate the traffic, turnover and activity of their target proteins. Rhomboid domain containing 2 (RHBDD2) is a rhomboid family member overexpressed during mammary gland development and advanced stages of breast cancer. Interactome profiling studies have identified RHBDD2 as a novel binding partner of WW domain-containing oxidoreductase (WWOX) protein. The present study characterized the RHBDD2-WWOX interaction in proliferating and differentiated stages of normal mammary and breast cancer cells by co-immunoprecipitation and confocal microscopy. Normal breast and proliferating cancer cells showed significantly increased RHBDD2 mRNA levels compared with their differentiated counterparts. WWOX mRNA was primarily expressed in differentiated cells. WWOX co-precipitated with RHBDD2, indicating that endogenous RHBDD2 and WWOX were physically associated in normal and breast cancer proliferating cells compared with the differentiated stage. Co-localization assays corroborated the co-immunoprecipitation results, demonstrating the RHBDD2-WWOX protein interaction in normal and proliferating breast cancer cells. RHBDD2 harbors a conserved LPPY motif at the C-terminus region that directly interacted with the WW domains of WWOX. Since WWOX serves as an inhibitor of the TGF beta/SMAD3 signaling pathway in breast cells, modulation of SMAD3 target genes was analyzed in proliferating and differentiated mammary cells and in RHBDD2 silencing assays. Increased expression levels of SMAD3-regulated genes were detected in proliferating cells compared with their differentiated counterparts. Follistatin and angiopoietin-like 4 mRNA was significantly downregulated in RHBDD2 transiently silenced cells compared with scrambled control small interfering RNA. Based on these results, WWOX was suggested to be a novel RHBDD2 target protein involved in the modulation of breast epithelial cell proliferation and differentiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据